US 11033570
Modulation of Lnc05 expression
granted A61KA61K31/7125A61K31/713
Quick answer
US patent 11033570 (Modulation of Lnc05 expression) held by Ionis Pharmaceuticals, Inc. expires Mon Jun 10 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Ionis Pharmaceuticals, Inc.
- Grant date
- Tue Jun 15 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 10 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 13
- CPC classes
- A61K, A61K31/7125, A61K31/713, A61K45/06, A61K9/0019